|
21 Nov 2025
|
Sudeep Pharma
|
Hem Securities
|
628.75
|
|
|
|
IPO Subscribe
|
|
|
Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem. Company leverage its inhouse developed technologies for processes such as encapsulation, spray drying, granulation, trituration, liposomal preparations and blending in an effort to drive innovation in its operations. Company have established a presence in both, domestic and international...
|
|
20 Nov 2025
|
Sudeep Pharma
|
Ventura
|
628.75
|
|
|
|
IPO Subscribe
|
|
|
|
|
20 Nov 2025
|
Sudeep Pharma
|
IDBI Capital
|
628.75
|
|
|
|
IPO Note
|
|
|
Sudeep Pharma is a technology driven manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries, supported by in-house capabilities in encapsulation, spray drying, granulation and liposomal preparations. The company is one of the largest producers of food grade iron phosphate and a leading exporter of mineral based ingredients from India, supplying to more than 100 countries. Its regulatory credentials are a key strength, reflected in approvals such as USFDA, WHO-GMP, EXCiPACT and a rare CEP certification for calcium carbonate in the European Union. The company's...
|
|
19 Nov 2025
|
Sudeep Pharma
|
SBI Securities
|
628.75
|
|
|
|
IPO Subscribe
|
|
|
Sudeep Pharma Ltd. (SPL) is a manufacturer of excipients and specialty ingredients for the pharmaceuticals, food and nutrition industries. The company has an established presence in both domestic and international markets, including key regions such as the US, South America, Europe, the Middle East, Africa and AsiaPacific. SPL is the largest producer of food-grade iron phosphate for infant nutrition, clinical nutrition and the F&B sector, in terms of production capacity,...
|